Levels and Significance of Adiponectin and Lipoproteins in Serum of Preeclampsia

doi:10.3877/cma.j.issn.1673-5250.2012.01.004

Objective

To explore the relationship between adiponectin (APN) and lipoproteins in the late pregnancy women with preeclampsia (PE).

Methods

From October 2008 to October 2010, a total of 40 cases of pregnancy women with PE were admitted in the Second Affiliated Hospital of Qingdao Medical University as PE group. According to severity grading of PE [severe preeclampsia (SPE) and mild preeclampsia(MPE)], they were divided into SPE group(n=22) and MPE group(n=18). Meanwhile another 40 healthy pregnancy women gestational ages as control group. The levels of serum APN, total triglyceride(TG), cholesterin(TC), low density lipoprotein(LDL)and high density lipoprotein (HDL) in 80 pregnant women at 34~38 weeks were measured with radioimmunoassay(RIA). There had no significant differences between PE group and control group, MPE group and SPE group among ages, gestational ages, parities(all first born), pregnant weight in late pregnancy, special past medical history and other pregnancy complications (P>0.05). This was a prospective observational study with institutional ethics approval and written subjects consent.

Results

①The levels of serum APN and HDL were significantly lower in PE group than those in control group(P<0.01). The TG level was significantly higher in PE group than that in control group(P<0.01). ②The levels of APN and TG were negative correlated in PE group(r=-0.90, P<0.01). The levels of APN and HDL were positive correlated in PE group(r=0.93, P<0.01).

Conclusions

Lower APN and disturbance of lipid metabolism in late pregnancy might be associated with the pathogenesis of PE.

Key words: preeclampsia, adiponectin, lipoprotein

表1 PE组与对照组一般情况比较(±s)

Table 1 Comparison of general clinical data between PE group and control group(±s)

组别	n	年龄(岁)	孕龄(孕周)	孕晚期体重(kg)
PE组	40	29.15±4.51	36.90±2.87	82.45±13.45
对照组	40	28.83±2.25	38.11±3.95	78.87±10.20
t	?	0.4016	1.5674	1.3413
P	?	0.6891	0.1211	0.1837

表1 PE组与对照组一般情况比较(±s)

Table 1 Comparison of general clinical data between PE group and control group(±s)

组别	n	年龄(岁)	孕龄(孕周)	孕晚期体重(kg)
PE组	40	29.15±4.51	36.90±2.87	82.45±13.45
对照组	40	28.83±2.25	38.11±3.95	78.87±10.20
t	?	0.4016	1.5674	1.3413
P	?	0.6891	0.1211	0.1837

表2 PE组与对照组血清APN，TG，TC，HDL及LDL水平比较 (±s)

Table 2 Comparison of levels of serum APN, TG, TC, HDL and LDL between PE group and control group (±s)

组别	n	APN(mg/mL)	TG(mmol/L)	TC(mmol/L)	HDL(mmol/L)	LDL(mmol/L)
PE组	40	9.65±1.87	5.76±1.32	4.96±0.92	1.64±0.32	3.52±0.98
对照组	40	12.33±1.65	4.98±1.08	4.73±0.87	2.08±0.51	3.14±0.81
t	?	6.7966	2.8925	1.1488	4.6220	1.8900
P	?	0.0000	0.0050	0.2541	0.0000	0.0624

表2 PE组与对照组血清APN，TG，TC，HDL及LDL水平比较 (±s)

Table 2 Comparison of levels of serum APN, TG, TC, HDL and LDL between PE group and control group (±s)

组别	n	APN(mg/mL)	TG(mmol/L)	TC(mmol/L)	HDL(mmol/L)	LDL(mmol/L)
PE组	40	9.65±1.87	5.76±1.32	4.96±0.92	1.64±0.32	3.52±0.98
对照组	40	12.33±1.65	4.98±1.08	4.73±0.87	2.08±0.51	3.14±0.81
t	?	6.7966	2.8925	1.1488	4.6220	1.8900
P	?	0.0000	0.0050	0.2541	0.0000	0.0624

表3 MPE组与SPE组血清APN，TG，TC，HDL及LDL水平比较 (±s)

Table 3 Comparison of levels of serum APN, TG, TC, HDL and LDL between MPE group and SPE group (±s)

组别	n	APN(mg/mL)	TG(mmol/L)	TC(mmol/L)	HDL(mmol/L)	LDL(mmol/L)
MPE组	18	11.14±1.17	5.51±0.36	4.95±0.27	1.81±0.13	3.49±0.47
SPE组	22	6.51±1.50	5.98±0.63	4.97±0.33	1.50±0.07	3.55±0.59
t	?	10.9524	2.8004	0.2721	9.7599	0.3586
P	?	0.0000	0.0080	0.7870	0.0000	0.7219

表3 MPE组与SPE组血清APN，TG，TC，HDL及LDL水平比较 (±s)

Table 3 Comparison of levels of serum APN, TG, TC, HDL and LDL between MPE group and SPE group (±s)

组别	n	APN(mg/mL)	TG(mmol/L)	TC(mmol/L)	HDL(mmol/L)	LDL(mmol/L)
MPE组	18	11.14±1.17	5.51±0.36	4.95±0.27	1.81±0.13	3.49±0.47
SPE组	22	6.51±1.50	5.98±0.63	4.97±0.33	1.50±0.07	3.55±0.59
t	?	10.9524	2.8004	0.2721	9.7599	0.3586
P	?	0.0000	0.0080	0.7870	0.0000	0.7219

1	Ramsay JE, Jamieson N, Greer IA, et al.Paradoxical elevation in adiponectin concentrations in women with preeclampsia[J]．Hypertension，2003，42:891-894.
2	Wolf M, Hubel CA, Lain C, et al.Preelampsia and future cardiovascular disease: Potential role of altered angiogensis and insulin resistance[J]．Clin Endocrinol Metab，2004，89(12):6239-6243.
3	Scherer PE, Wiliam S, Fogliano M, et al.A novel serum protein similar to Clq, produced excllusively in adipocytes[J]. J Biol Chem，1995，270:26746-26749.
4	Haluzik M, Parizkova J, Haluzik MM.Adiponectin and its role in the obesity－induced insulin resistance and related complications[J]．Physiol Res，2004，53(1):123-129.
5	Mazaki-Tovi S, Kanety H, Sivan E．Adiponectin and human pregnancy[J]．Curr Diab Rep，2005，53(4):278-281.
6	Ouchi N, Kihara S, Arita Y, et al.Adiponectin，an adipocyte－derived plasma protein.Inhibits endothelial NF－α Kappa B signaling through a cAMP－dependent pathway[J]．Circulation，2000，102(11):1296-1301.
7	Redman CW, Sargent IL.Latest advances in understanding preeclampsia[J]. Science，2005，308 (5728):1592-1594.
8	Sibai B, Dekker G, Kupferminc M．Preeclampsia[J]. Lancet，2005，365(9461):785-799.
9	D'Anna R, Baviera G, Corrado F, et al.Plasma adiponectin concentration in early pregnancy and subsequent risk of hypertensive disorders[J]. Obstet Gynecol，2005，106 (2):340.
10	Naruse K, Yamasaki M, Umekage H, et al. Peripheral blood concentrations of adiponectin，an adipocyte－specific plasma protein, in normal pregnancy and preeclampsia[J]. J Reprod Immunol，2005，65(1):65-75.
11	Fernandez-Real JM, Lopez-Bermejo A, Casamit JR, et al. Novel interactions of adiponectin with the endocrine system and inflammatory parameters[J]．J Clin Endoerinol Metab，2003，88:2714-2718.

[1]	Jian Zhuang, Changjie Pan, Xiaoqin Li, Mengxia Yu, Chao Zhang, Weiwen Zhu. Clinical value of shear wave elastography in evaluating placental elasticity in patients with preeclampsia[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2022, 19(07): 660-666.
[2]	Danyan Feng, Xiaohui Cao, Yuxia Shi. Effect of serum adiponectin and placental leucine aminopeptidase levels on pregnancy outcome in pregnant women with gestational diabetes mellitus[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(03): 302-308.
[3]	Xiaoyu Yang, Qianqian Fu, Miaomiao Zhang, Yamei Zhao, Xiaoping Yu, Junli Zhou. Analysis of pathogenic bacteria and relevant factors of diabetes foot wound infection in a third-class hospital in Gansu Province[J]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2023, 18(01): 16-24.
[4]	Longfei Zhang, Yong Gao, Yigang Zhang, Chaowen Yu, Delang Liu, Ya Liu, Shiyuan Chen. Expression and clinical significance of Apolipoprotein B, sex hormone binding globulin and tissue inhibitors of metalloproteinase 1 in Budd-Chiari syndrome of inferior vena cava in northern Anhui[J]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(04): 252-256.
[5]	Xianmei Wei, Yu Han, Yingcai Jiang. Knockdown of circSERPINE2 inhibits trophoblast cell proliferation, migration and invasion by targeting miR-34a-5p expression[J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2023, 13(04): 193-201.
[6]	Yueyan Xiao, Wenbin Wei, Ping Xi, Bo Gao, Jianan Wang, Yunyun Geng, Min Zheng, Fengying Jiao. Epidemiological analysis on the systemic risk factors for the idiopathic macular membrane in the community residents over 60 years old[J]. Chinese Journal of Ophthalmologic Medicine(Electronic Edition), 2022, 12(05): 281-286.
[7]	Meiqing Wu, Jin Lin, Meili Duan, Xiaoyan Xue. Effect of high density lipoprotein level on the occurrence of sepsis-related acute respiratory distress syndrome[J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2023, 09(02): 191-197.
[8]	Rui Tan, Jing Wang, Jiangquan Yu, Ruiqiang Zheng. Progress in understanding of role of high density lipoprotein, apolipoprotein A-I, and serum amyloid A in sepsis[J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(06): 749-753.
[9]	Jie Chen, Yi Bai, Jinbo Liu, Huan Liu, Na Zhao, Hongwei Zhao, Hongyu Wang. Correlation between neutrophil/high-density lipoprotein ratio and lower extremity arterial disease in middle-aged and elderly people[J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(04): 402-408.
[10]	Haihong Song, Ping Li, Xianxia Chen. Relationship of uterine arterial pulsatility index, peripheral blood fetal hemoglobin, and placental growth factor level with outcome of early-onset preeclampsia re-pregnancy[J]. Chinese Journal of Clinicians(Electronic Edition), 2022, 16(11): 1109-1114.
[11]	Ling Xie, Chunxia Huo, Aiping Zhang. Diagnostic and predictive value of sFlt-1 and PLGF for preeclampsia in pregnant women[J]. Chinese Journal of Clinicians(Electronic Edition), 2022, 16(09): 902-907.
[12]	Xiaofang Zheng, Songquan Wei, Zhenxuan Huang, Wenshi Wu, Guimin Li, Hongxia Zhang, Qingping Jiang, Dunjin Chen, Lin Yu. Pregnancy outcome and pathological changes of the placenta in preeclampsia with fetal growth restriction[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2023, 12(02): 85-92.
[13]	Fang He. Thrombophilia and preeclampsia[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2023, 12(01): 6-11.
[14]	Meijuan Yan, Lihui Shao. Correlation between lipoprotein (a) and arteriosclerotic cerebral small vessel disease in elderly population without diabetes, hyperlipidemia and hypertension[J]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2023, 17(05): 458-463.
[15]	Lingzhi Qiu, Ping Hu, Ting Luo, Hua Yan. Research progress of the relationship between lipoprotein(a) and atrial fibrillation[J]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2023, 17(03): 280-284.

Viewed

Full text

Abstract

Please choose a citation manager

Content to export